HUESnap
Cloud-based AI diagnostic pipeline for smartphone-based colorimetric biomarker quantification
Company profile
Company profile
PocDoc is a UK-based health technology company revolutionising point-of-care diagnostics through smartphone-enabled blood testing. The company has developed an app-based technology platform that combines proprietary Microfluidic Assay (MFA) technology with cloud-based AI diagnostics to deliver end-to-end digital pathways for the assessment, diagnosis and treatment of Cardio, Metabolic and Renal (CMR) diseases. Their flagship product, the Healthy Heart Check, provides fully quantified lab-grade lipid panel results in under 10 minutes from a simple finger-prick blood test. The platform delivers a complete 5-marker cholesterol panel including Total Cholesterol, HDL, Non-HDL/LDL, Triglycerides, and Total Cholesterol/HDL ratio, along with Heart Age and 10-year cardiovascular disease risk calculations compared against NHS clinical guidelines. PocDoc offers solutions for both healthcare professionals (PocDoc Pro) and individual consumers, with the professional version integrating with electronic health records and clinical risk engines. The company's mission is to prevent millions of premature deaths by identifying those at highest risk of CMR diseases, addressing the critical access gap where millions of at-risk individuals have never been tested. Founded by a multidisciplinary team of scientists, entrepreneurs and healthcare professionals, PocDoc is working to make diagnostics accessible for all, particularly those at highest risk who face barriers to traditional testing.
Company description PocDoc official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · Hybrid deployment with recorded integration context.
Recorded integration context: Clinical risk engines, Electronic Health Records, Insurer systems.
Company milestones
CEO Steve Roest is member of UK Research and Innovation Future Leaders review board. Multiple Innovate UK grant awards received.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Cloud-based AI diagnostic pipeline for smartphone-based colorimetric biomarker quantification
At-home finger-prick cholesterol test with heart age and CVD risk in under 10 minutes
Patented portable quantitative digital diagnostic test platform for multi-marker analysis
Point-of-care multi-marker blood testing platform for healthcare professionals
Digital infrastructure platform for point-of-care testing with EHR integration and population health management
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Citing American Heart Association research
Point-of-care testing turnaround time
Clinical accuracy of 5-marker lipid panel
05 · Leadership
Leadership profiles and professional links from the current Company record.
Steve Roest
CEO & Co-Founder
Kiran Roest
Chief Strategy Officer & Co-Founder
Vladimir Gubala
Chief Scientific Officer & Co-Founder
06 · Company updates
Recent articles published on PocDoc's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.